EPISONA, INC.

Episona's first product, Seed, is an epigenetic test for male infertility focused on decreasing cost and time to pregnancy for those seeking fertility care. Clinically, Seed can identify 1) hidden male factor in cases of unexplained infertility and 2) epigenetic patterns that strongly associate with poor embryogenesis. Episona is led by an experienced team of medical doctors and scientists, with world-class expertise in both epigenetics and human reproductive health. The company began operations in 2013 and is headquartered in Pasadena, CA. For more information, visit https://episona.com.